-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RcU80e+7BK6Nt/oSIIfu+Ono2Y7det+U3mmhj+ZT9HA+5Xxo7UYXSoOFj3Y0NjkE Q/eiDTBajfcEt/QpecQy0w== 0001140484-05-000007.txt : 20050314 0001140484-05-000007.hdr.sgml : 20050314 20050314162538 ACCESSION NUMBER: 0001140484-05-000007 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050304 FILED AS OF DATE: 20050314 DATE AS OF CHANGE: 20050314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WALTON ALAN G CENTRAL INDEX KEY: 0001214273 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678696 MAIL ADDRESS: STREET 1: ALEXANDRIA REAL ESTATE EQUITIES INC STREET 2: 135 N LOS ROBLES AVE SUITE 250 CITY: PASADENA STATE: CA ZIP: 91101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYTTON MICHAEL CENTRAL INDEX KEY: 0001286396 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678697 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: STE 1650 CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLEMING JONATHAN CENTRAL INDEX KEY: 0001262294 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678698 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTHY MARK CENTRAL INDEX KEY: 0001286397 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678699 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: STE 1650 CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OBP MANAGEMENT IV LP CENTRAL INDEX KEY: 0001286541 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678701 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MRNA FUND II LP CENTRAL INDEX KEY: 0001161302 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678702 BUSINESS ADDRESS: STREET 1: 31 ST JAMES AVENUE STREET 2: SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-357-7474 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OXFORD BIOSCIENCE PARTNERS IV LP CENTRAL INDEX KEY: 0001140484 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678703 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: SUITE 1650 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6173577474 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARNES JEFFREY T CENTRAL INDEX KEY: 0001261294 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05678700 BUSINESS ADDRESS: STREET 1: CRITICARE SYSTEMS INC. STREET 2: 20925 CROSSROADS CIRCLE CITY: WAUKESHA STATE: WI ZIP: 53186 BUSINESS PHONE: 262-798-5380 MAIL ADDRESS: STREET 1: CRITICARE SYSTEMS, INC. STREET 2: 20925 CROSSROADS CRICLE, SUITE 100 CITY: WAUKESHA STATE: WI ZIP: 53186 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2005-03-04 0 0000913275 Solexa, Inc. SLXA 0001140484 OXFORD BIOSCIENCE PARTNERS IV LP 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 0001161302 MRNA FUND II LP 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 0001286541 OBP MANAGEMENT IV LP 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 0001261294 BARNES JEFFREY T 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 0001286397 CARTHY MARK 222 BERKELEY ST. BOSTON MA 02116 1 0 1 0 0001262294 FLEMING JONATHAN 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 0001286396 LYTTON MICHAEL 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 0001214273 WALTON ALAN G 222 BERKELEY ST. BOSTON MA 02116 0 0 1 0 Common 2468986 D Common 24771 I By mRNA Fund II L.P. Securities held of record by Oxford Bioscience Partners IV L.P. ("Oxford IV"). By virtue of their relationship as affiliated limited partnerships, whose sole general partner shares individual general partners, Oxford IV and mRNA Fund II L.P. ("mRNA") may be deemed to share voting power and the power to direct the disposition of the shares which each partnership owns of record. OBP Management IV L.P. ("OBP IV") (as the general partner of Oxford IV and mRNA II), may also be deemed to own beneficially the shares held of record by Oxford IV and mRNA II. Each of Messrs. Barnes, Carthy (who is a Director of the issuer), Fleming, Lytton, and Walton, the individual general partners of OBP IV, may be deemed to own beneficially the shares held by Oxford IV and mRNA II. Securities held of record by mRNA. By virtue of their relationship as affiliated limited partnerships, whose sole general partner shares individual general partners, Oxford IV and mRNA may be deemed to share voting power and the power to direct the disposition of the shares which each partnership owns of record. OBP IV (as the general partner of Oxford IV and mRNA II), may also be deemed to own beneficially the shares held of record by Oxford IV and mRNA II. Each of Messrs. Barnes, Carthy (who is a Director of the issuer), Fleming, Lytton, and Walton, the individual general partners of OBP IV, may be deemed to own beneficially the shares held by Oxford IV and mRNA II. /s/ Jonathan J. Fleming, as general partner of the general partner of Oxford Bioscience Partners IV L.P. 2005-03-14 /s/ Jonathan J. Fleming, as general partner of the general partner of mRNA Fund II L.P. 2005-03-14 /s/ Jonathan J. Fleming, as general partner of OBP Management IV L.P. 2005-03-14 /s/ Raymond Charest, as attorney-in-fact for Jeffrey T. Barnes 2005-03-14 /s/ Mark P. Carthy 2005-03-14 /s/ Jonathan J. Fleming 2005-03-14 /s/ Michael E. Lytton 2005-03-14 /s/ Alan G. Walton 2005-03-14 EX-24 2 poa.txt EXHIBIT 24 - POWER OF ATTORNEY Exhibit 24 - POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Raymond Charest, Alexia Pearsall and Jonathan J. Fleming, and each of them, with full power to act without the other, his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities (until revoked in writing) to sign any and all instruments, certificates and documents required to be executed on behalf of himself as an individual or in his capacity as a general partner or authorized signatory, as the case may be, on behalf of any of Oxford Bioscience Partners IV L.P., mRNA II L.P., or OBP Management IV L.P., pursuant to section 13 or 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the National Association of Securities Dealers, Inc., granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as he might or could do in person thereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof, or may have done in connection with the matters described above. IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 8th day of April, 2004. OXFORD BIOSCIENCE PARTNERS IV L.P. by its General Partner, OBP MANAGEMENT IV L.P. By: /s/ Jonathan Fleming Name: Jonathan J. Fleming Title: General Partner MRNA FUND II L.P. By its General Partner, OBP MANAGEMENT IV L.P. By: /s/ Jonathan Fleming Name: Jonathan J. Fleming Title: General Partner OBP MANAGEMENT IV L.P. By:/s/ Jonathan Fleming Name: Jonathan J. Fleming Title: General Partner /s/ Jeffrey T. Barnes Jeffrey T. Barnes /s/ Mark P. Carthy Mark P. Carthy /s/ Jonathan J. Fleming Jonathan J. Fleming /s/ Michael E. Lytton Michael E. Lytton /s/ Alan G. Walton Alan G. Walton -----END PRIVACY-ENHANCED MESSAGE-----